The Statistical Center of the International Bone Marrow Transplant Registry (IBMTR) and the Autologous Blood and Marrow Transplant Registry of North America (ABMTR) coordinates an international effort to collect and analyze data on outcome of blood and bone marrow (hematopoietic stem cell) transplants. The IBMTR, established in 1972, and the ABMTR, established in 1990, involve greater than 400 transplant centers in 47 countries. Participating centers submit data on consecutive transplants to the IBMTR/ABMTR Statistical Center. The Registries have data for greater than 65,000 transplants. These data are used for determining transplant results in specific clinical situations, identifying prognostic factors, comparing transplant regimens, comparing transplant with non-transplant therapy, assessing intercenter variability in diagnosis, practice and outcome, evaluating transplant costs and cost- effectiveness, planning clinical trials or treatment protocols, and developing approaches to evaluating transplant outcome. Statistical Center personnel have a strong record of expert and innovative analyses of these and other issues using IBMTR/ABMTR data. The proposed grant will support continued development of this unique resource of data and statistical expertise. The proposal outlines several enhancements to the Statistical Center's data collection, entry and management system, including addition of cost information, that will ensure availability of demographic, medical and financial data on a large and representative group of transplant recipients for use by the scientific community. The proposal includes several strategies to increase awareness of this resource and enhance its availability to investigators and health policy makers, including development of a public use database. The project will also develop statistical methodologies appropriate for unbiased and efficient analyses of transplant data and provide expert statistical support for studies using IBMTR/ABMTR data.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
5U24CA076518-05
Application #
6513336
Study Section
Special Emphasis Panel (ZCA1-RLB-7 (O6))
Program Officer
Wu, Roy S
Project Start
1998-03-01
Project End
2003-02-28
Budget Start
2002-04-15
Budget End
2003-02-28
Support Year
5
Fiscal Year
2002
Total Cost
$2,369,950
Indirect Cost
Name
Medical College of Wisconsin
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073134603
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Slack, James; Albert, Michael H; Balashov, Dmitry et al. (2018) Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders. J Allergy Clin Immunol 141:322-328.e10
Harris, Andrew C; Boelens, Jaap J; Ahn, Kwang Woo et al. (2018) Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine. Blood Adv 2:1198-1206
Chhabra, Saurabh; Liu, Ying; Hemmer, Michael T et al. (2018) Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation. Biol Blood Marrow Transplant :
Chhabra, Saurabh; Ahn, Kwang Woo; Hu, Zhen-Huan et al. (2018) Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia. Blood Adv 2:2922-2936
Marsh, Rebecca A; Hebert, Kyle M; Keesler, Daniel et al. (2018) Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies. J Allergy Clin Immunol 142:2004-2007
Ahn, Kwang Woo; Sahr, Natasha; Kim, Soyoung (2018) Screening group variables in the proportional hazards model. Stat Probab Lett 135:20-25
Strouse, Christopher; Zhang, Ying; Zhang, Mei-Jie et al. (2018) Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant. Biol Blood Marrow Transplant 24:2072-2080
Elgarten, Caitlin W; Arnold, Staci D; Li, Yimei et al. (2018) Hospital-Level Variability in Broad-Spectrum Antibiotic Use for Children With Acute Leukemia Undergoing Hematopoietic Cell Transplantation. Infect Control Hosp Epidemiol 39:797-805
Eapen, Mary; Brazauskas, Ruta; Hemmer, Michael et al. (2018) Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity. Blood Adv 2:2095-2103
Shah, Nirav N; Ahn, Kwang Woo; Litovich, Carlos et al. (2018) Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis. Blood Adv 2:933-940

Showing the most recent 10 out of 641 publications